It’s a Dutch Treat! 

The 3rd annual Immunogenicity and Tolerance Seminar is scheduled for the 9th of November, 2017.

This ​meeting ​will ​focus ​on ​the ​determinants ​of ​immunogenicity ​– ​a ​key ​feature ​of ​effective ​vaccines ​and ​a ​key ​barrier ​to ​success ​in ​the ​clinic ​for ​protein ​therapeutics. ​Conversely, ​tolerance ​induction ​is ​a ​key ​feature ​of ​successful ​protein ​therapeutics, ​while ​suppressing ​immune ​responses ​to ​vaccines. ​The ​reduction ​of ​T ​cell ​epitopes ​and ​introduction ​of ​Treg ​epitopes ​(like ​Tregitopes) ​for ​protein ​therapeutics, ​and ​the ​reverse ​process ​for ​vaccines, ​will ​be ​discussed ​and ​illustrated ​in ​case ​studies. ​

Click Here to Register

Enjoy engaging presentations, case studies and discussions with speakers to include Dr. Annie ​De ​Groot, MD (EpiVax CEO), Marieke ​van ​Ham, PhD (Sanquin), Wim ​Jiskoot, ​PhD (Leiden ​University ​Medical ​Center), Vincent ​Lombardi, ​PhD (Stallergenes), Ab ​Osterhaus, ​PhD (University ​of ​Veterinary ​Medicine ​in ​Hannover, ​Germany), Bram ​Slütter, ​PhD (Leiden ​University) and Jagadeesh ​Bayry (Institut ​National ​de ​la ​Santé ​et ​de ​la ​Recherche ​Médicale ​(INSERM) ​Unité).
Food, refreshments and cocktail hour to conclude.
Register today to reserve your seat, and discover the positive reputation of our seminar:

“Good combination of talks about determinants of immunogenicity and tolerance. Very well hosted by Annie; made good connections between people in audience Good networking possibilities”

“Wide variety of topics related to immunogenicity, it forces us to go outside of our usual domain of expertise.”